JP Morgan Chase
TERN

JP Morgan Chase’s Terns Pharmaceuticals TERN Stock Holding History

JP Morgan Chase’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-115,800
Closed -$966K – 7725
2024
Q3 		$966K Buy
+115,800
New +$953K ﹤0.01% 4487

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's TERN Position: Q2 2026 in Review

JP Morgan Chase sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 2,869,728 shares — an estimated $152M sold.

JP Morgan Chase first reported a position in TERN in Q1 2021 and held it in 21 quarters. The position peaked at $152M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • JP Morgan Chase reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • JP Morgan Chase sold 2,869,728 Terns Pharmaceuticals shares in Q2 2026, an estimated $152M.
  • JP Morgan Chase first reported a position in Terns Pharmaceuticals in Q1 2021 and held it in 21 quarters.
  • JP Morgan Chase's Terns Pharmaceuticals position peaked at $152M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.